Abstract
The present disclosure relates to (S)-(2-(5-chloro-4-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl) (5-methoxy-2-(2H-1,2,3-triazol-2-yl) phenyl) methanone hydrochloride, is represented by following structural formula (1).
The present disclosure relates to a process for the preparation of an intermediate of compound of formula (1), the intermediate is represented by following structural formula (2).
The present disclosure relates to a process for the preparation of an intermediate of compound of formula (1), the intermediate is represented by following structural formula (5).
The present disclosure relates to a process for the preparation of an intermediate of compound of formula (1), the intermediate is represented by following structural formula (6).
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Recommended Citation
Lee Pharma Limited, "AN IMPROVED PROCESS FOR THE PREPARATION OF AN OREXIN RECEPTOR ANTAGONIST", Technical Disclosure Commons, ()
https://www.tdcommons.org/dpubs_series/11783